文献速递脊柱关节炎

什么是外周型脊柱关节炎?在ASAS-PerSpA研究的事后分析中识别其比例、表型和疾病负担

What is peripheral spondyloarthritis? Identifying proportion, phenotype and burden in post hoc analysis of the ASAS-PerSpA study.
PubMed 文献 · Semin Arthritis Rheum · 2022-04-21

该研究为ASAS-PerSpA横断面研究的事后分析,纳入4185例脊柱关节炎(SpA)患者,分别按分类标准途径和诊断途径评估外周型SpA(pSpA)的比例、表型与负担。按分类标准途径pSpA占31.5%,按诊断途径占10.3%;纯pSpA在两种途径下分别占pSpA的16.8%和62.3%。与纯银屑病关节炎(PsA)和纯中轴型SpA(axSpA)相比,纯pSpA疾病负担显著更高但生物制剂使用更低。

要点

  • 按分类标准途径pSpA占SpA的31.5%,按诊断途径占10.3%。
  • 纯pSpA在分类标准途径下占pSpA的16.8%,诊断途径下占62.3%。
  • 纯pSpA较纯PsA和纯axSpA疾病负担显著更高,但生物制剂使用更低。

核心结论

  • 使用分类标准或诊断途径时pSpA的比例不同。
  • pSpA以纯形式出现的频率低于PsA和axSpA,具有中间特征但疾病负担更高。

研究设计与样本

  • 该研究为对ASAS-PerSpA横断面研究4185例患者的事后分析。
  • 患者通过两种途径纳入:基于风湿科医生诊断的诊断途径和基于满足ASAS或CASPAR分类标准的分类标准途径。
  • 比较纯pSpA、PsA、axSpA及混合型SpA的人口学、疾病表型和负担。

主要发现

  • 按分类标准途径pSpA占SpA的31.5%,按诊断途径占10.3%。
  • 纯pSpA在分类标准途径下占pSpA的16.8%,在诊断途径下占62.3%。
  • 按分类标准和诊断途径,纯pSpA患者外周关节病患病率分别为86%和96%,滑膜炎分别为76%和91%,附着点炎分别为57%和55%。
  • 按分类标准和诊断途径,纯pSpA患者HLA-B27阳性分别为65%和59%,高C反应蛋白水平分别为51%和52%,炎性背痛分别为42%和52%。
  • 与纯PsA和纯axSpA相比,纯pSpA在两种途径下疾病负担显著更高,但生物制剂使用更低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little is known about the prevalence, phenotype, and burden of peripheral spondyloarthritis (pSpA). The objective of the study is to compare the phenotype and burden of disease of pure pSpA to that of pure psoriatic arthritis (PsA), pure axial SpA (axSpA), and combined forms of SpA. METHODS: This is a post hoc analysis of 4,185 patients from the cross-sectional ASAS-Peripheral involvement in SpA (PerSpA) study. Patients were approached in 2 ways: the first approach was based on the rheumatologist's diagnosis (diagnostic approach) and the second one was based on the fulfillment of ASAS or CASPAR classification criteria (classification criteria approach). Demographics, disease phenotype, and burden were compared among pure pSpA, PsA, axSpA, and the combined forms. FINDINGS: The proportion of pSpA was 31.5% of SpA using the classification criteria approach and 10.3% using the diagnostic approach. pSpA was pure (i.e. without axSpA or PsA) in 16.8% of pSpA using the criteria, and in 62.3% using the diagnostic approach. Using classification criteria and diagnostic approach, respectively, pure pSpA patients had a high prevalence of peripheral joint disease (86 and 96%), synovitis (76 and 91%), and enthesitis (57 and 55%), a positive HLA-B27 in 65 and 59%, a high C-Reactive Protein level in 51% and inflammatory back pain in 52 and 42%. However, compared to pure PsA and pure axSpA, they had a significantly higher disease burden, but lower use of biologics using both approaches. INTERPRETATION: The proportion of pSpA varies when using the classification criteria or the diagnostic approach. pSpA occurred in a pure form less frequently than PsA and axSpA and had intermediate features but a higher disease burden. FUNDING: The PerSpA main study has been conducted under the umbrella of ASAS thanks to unrestricted grants from PFIZER, LILLY, ABBVIE, NOVARTIS, UCB, JANSSEN, MERCK.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Ziade N, Rassi J, Elzorkany B, et al. What is peripheral spondyloarthritis? Identifying proportion, phenotype and burden in post hoc analysis of the ASAS-PerSpA study. Semin Arthritis Rheum. 2022. PMID: 35489171. doi:10.1016/j.semarthrit.2022.152012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。